S&P Global Inc (SPGI)

S&P Global Inc. (SPGI) sees a surge in social engagement and mentions, with a director making a significant insider purchase of over $1 million in shares, signaling potential undervaluation amidst market volatility.

About S&P Global Inc

S&P Global Inc. is a financial services company providing credit ratings, benchmarks, analytics, and data to capital and commodity markets worldwide.
S&P Global Inc uses the ticker $SPGI for trading. Listed in the Stocks category within the Financial Services sectors.

Insights

S&P Global Inc (SPGI) social dominance is up 1426.92% from the previous week.
S&P Global Inc (SPGI) Galaxy Score™ is up 29.63% from the previous month.
S&P Global Inc (SPGI) sentiment is up 12.86% from the previous week.
S&P Global Inc (SPGI) creators is up 223.43% from the previous month.
S&P Global Inc (SPGI) engagements is up 349.91% from the previous month.
S&P Global Inc (SPGI) mentions is up 190.85% from the previous month.
S&P Global Inc (SPGI) posts created is up 233.21% from the previous month.
S&P Global Inc entered the top [--] AltRank™ for the first time

Price: $409.50

Price 24-Hour Time-Series Raw Data
The stock price has experienced a significant decline attributed to weak forward guidance and general market volatility. However, a notable increase in insider buying suggests some believe the current valuation presents a buying opportunity.

24-Hour: 2.6% 7-Day: -7.75% 30-Day: -25.04%

1-Year High: $564.20 on 2025-08-14
1-Year Low: $390.80 on 2026-02-11

AltRank: [---]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
S&P Global Inc (SPGI) is currently AltRank #288 based on combined combined social and market metrics Daily Average: [---]
[--] Week: [---] +74
[--] Month: [---] +142
[--] Months: [---] [----]
[--] Year: [---] [---]
1-Year High: [-----] on 2025-06-30
1-Year Low: [--] on 2025-07-20

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +9
[--] Month: [--] +16
[--] Months: [--] +12
[--] Year: [--] +21
1-Year High: [--] on 2025-05-08
1-Year Low: [--] on 2025-09-05

Engagements: [-------] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [-------]
Daily Average: [-------]
[--] Week: [---------] +110%
[--] Month: [---------] +350%
[--] Months: [----------] +39%
[--] Year: [----------] +80%
1-Year High: [---------] on 2025-02-28
1-Year Low: [------] on 2025-04-18

Engagements by network (24h): YouTube: [-----] News: [--] X: [-------] Instagram: [--] Reddit: [--] TikTok: [-----]

Mentions: [-----] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [---]
[--] Week: [-----] +112%
[--] Month: [-----] +191%
[--] Months: [------] -37%
[--] Year: [------] +72%
1-Year High: [-----] on 2025-07-03
1-Year Low: [---] on 2025-12-07

Mentions by network (24h): YouTube: [--] News: [--] X: [-----] Instagram: [--] Reddit: [--] TikTok: [--]

Creators: [---] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning S&P Global Inc (SPGI) in the last [--] hours which is down 11% from [---] in the previous [--] hours Daily Average: [---]
[--] Week: [-----] +96%
[--] Month: [-----] +223%
[--] Months: [-----] -53%
[--] Year: [------] +194%
1-Year High: [-----] on 2025-07-03
1-Year Low: [--] on 2025-12-07

The most influential creators that mention S&P Global Inc in the last [--] hours

Creator	Rank	Followers	Posts	Engagements
@CEOStockWatcher	[--]	[------]	[--]	[------]
@gainify_io	[--]	[------]	[--]	[------]
@DrewCohenMoney	[--]	[-----]	[--]	[------]
@yummyCenturyEgg	[--]	[-----]	[--]	[-----]
@DimitryNakhla	[--]	[------]	[--]	[-----]
@snipetrades	[--]	[------]	[--]	[-----]
@FluentInQuality	[--]	[-----]	[--]	[-----]
@realroseceline	[--]	[------]	[--]	[-----]
@grok	[--]	[---------]	[--]	[-----]
@TacticzH	[--]	[------]	[--]	[-----]

Sentiment: 78%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 78%
Daily Average: 84%
[--] Week: 79% +9%
[--] Month: 72% -10%
[--] Months: 72% -14%
[--] Year: 72% -16%
1-Year High: 98% on 2025-07-03
1-Year Low: 55% on 2025-05-13

Most Supportive Themes:

Positive Sentiment and Market Performance: (35%) Posts highlighting S&P Global's strong market position, positive financial metrics, and favorable credit rating actions, particularly in relation to India.
Dividend and Investment Opportunities: (25%) Posts mentioning dividend payouts and the stock's valuation, encouraging buying the dip and highlighting the company's strong fundamentals.
Duopoly and Market Dominance: (15%) Posts emphasizing S&P Global's strong market position and the duopoly it shares with Moody's in the credit ratings market.

Most Critical Themes:

Market Volatility and Data Releases: (10%) Posts discussing upcoming economic data releases and potential market volatility, with some cautioning about the stock's performance.
Sector and Peer Performance: (15%) Posts noting the decline in financial data stocks, including S&P Global, and comparing its performance to peers like FactSet and Morningstar.

Social Dominance: 0.08%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.08%
Daily Average: 0.066%
[--] Week: 1.60% +1.50%
[--] Month: 0.12% +0.063%
[--] Months: 0.12% +0.064%
[--] Year: 0.12% +0.04%
1-Year High: 0.253% on 2025-07-03
1-Year Low: 0.021% on 2025-12-07

Market Dominance: 0.139%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.139%
Daily Average: 0%
1-Year High: 0.299% on 2025-04-01
1-Year Low: 0.134% on 2026-02-11

Market Cap: $122,418,360,000

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $122,418,360,000
Daily Average: $155,165,837,686
[--] Week: $122,418,360,000 -8.10%
[--] Month: $122,370,552,000 -26%
[--] Months: $122,370,552,000 -28%
[--] Year: $122,370,552,000 -26%
1-Year High: $172,234,995,000 on 2025-08-14
1-Year Low: $116,759,088,000 on 2026-02-11

Top S&P Global Inc Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"Burggraben Aktien Cochlear Aktie Descartes Aktie Manhattan Associates Aktie 🏦 Mein Broker Transparente Gebhren starke Plattform ich nutze XTB selbst und kanns empfehlen. 👉 Jetzt registrieren: https://geolink.xtb.com/2Emk5 () 📢 Werbehinweis gem 5a UWG Bei dem mit () gekennzeichneten Link handelt es sich um einen Affiliate-Link. Wenn du darber etwas kaufst abschliet oder dich registrierst erhalte ich eine Provision fr dich entstehen keine zustzlichen Kosten. Dieses Video enthlt Werbung fr XTB im Rahmen einer bezahlten Kooperation. Durch deine Nutzung untersttzt du meine Arbeit und die"
YouTube Link @wealth 2026-02-16T17:46Z 12.6K followers, [---] engagements

"🚨 $SPGI SE DESPLOMA Oportunidad histrica o seal de alerta $SPGI se desploma en bolsa y muchos inversores se preguntan qu est pasando con S&P Global. En este anlisis detallado revisamos las posibles razones de la cada el impacto en su modelo de negocio el riesgo regulatorio la desaceleracin econmica y qu significa todo esto para inversores particulares. Analizamos si el desplome de SPGI es una oportunidad de inversin o una seal de alerta estructural. Tambin hablamos de mrgenes moat competitivo emisin de deuda mltiplos y valoracin. ---------------------------------------------------------- En"
YouTube Link @simplefinanzas 2026-02-16T17:00Z 18.9K followers, [---] engagements

"El SaaSmagedon - Acabar la IA con los proveedores de Datos financieros FactSet $FDS $SPGI $MSCI $LSEG $TRI https://youtu.be/9-Px3CTvwdE https://youtu.be/9-Px3CTvwdE"
X Link @VanguardEconomy 2026-02-16T16:02Z 19.2K followers, [----] engagements

"Earnings & Interesting Movers Recap: $HIMS Hims & Hers Health faced a material disruption to its growth trajectory following a combination of legal action from Novo Nordisk and a tightening regulatory stance from the FDA targeting non-approved GLP-1 therapies announced on Monday. Novo Nordisk sought a permanent injunction alleging patent infringement tied to compounded versions of semaglutide while regulators signaled intent to act against non-FDA-approved GLP-1 copies effectively challenging the framework that enabled large-scale compounding. The development directly targeted the companys"
X Link @PriceActionPLBK 2026-02-16T12:40Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing